The announcement directly pertains to Aehr Test Systems and is critical for investors as it signals a potential decrease in expected revenue, which is a key driver of stock performance. The negative impact on revenue is likely to be viewed unfavorably by the market, leading to a potential short-term decline in AEHR's stock price. The confidence level is not at 100 because the exact financial impact and investor reaction cannot be precisely predicted.